tiprankstipranks
Trending News
More News >
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
Advertisement

Day One Biopharmaceuticals (DAWN) Stock Investors

Compare
347 Followers
Based on 811,229 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DAWN
On average, investors allocate 2.17% of their portfolios to DAWN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 811,229 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DAWN

>0.1%
Last 7
Days
6.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DAWN, out of 811,229 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DAWN Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.72%
$12.88
Increased
0.56%
$11.92
Increased
0.64%
$7.90
Increased
0.18%
$6.67
Increased
1.36%
$6.57
Opened
0.00%
Based on the activity of investors who made their portfolios public
The table shows changes in DAWN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DAWN Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.79%
+1.22%
+1.77%
3.66B
Healthcare
Delta Air Lines
4.37%
-0.42%
-0.65%
34.74B
Industrials
CVS Health
3.67%
+1.12%
+1.76%
75.90B
Healthcare
Riot Platforms
4.71%
-0.64%
+3.11%
4.86B
Financial
Nio
6.18%
-0.35%
-1.06%
9.21B
Consumer Cyclical
Marathon Digital Holdings
4.70%
+1.94%
+1.27%
5.96B
Financial
Lucid Group
4.91%
+0.73%
+3.70%
7.87B
Consumer Cyclical
Block
3.52%
+0.72%
-0.07%
48.08B
Technology
Abbott Laboratories
3.15%
-0.13%
+6.24%
219.63B
Recursion Pharmaceuticals
3.20%
-0.17%
-0.57%
2.57B
Healthcare
Based on the activity of 811,229 active portfolios
Open your Smart Portfolio

DAWN Investor Analysis

DAWN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.7%
of DAWN holders
are under 35
Average Segment Performance
Average P/E Ratio24.01
Beta1.11
Dividend Yield4.06%
DAWN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
30.8%
of DAWN holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.59
Beta5.76
Dividend Yield5.55%
DAWN investors over 55

Over 55

4.8%
Last 30 days
Holdings Change
61.5%
of DAWN holders
are over 55
Average Segment Performance
Average P/E Ratio15.45
Beta2.29
Dividend Yield3.55%
Overview of age group and performance of DAWN stock investors
See who invests in DAWN according to age group and performance.

FAQ

How many retail Investors hold DAWN?
<0.1% of TipRanks' retail investors hold DAWN in their portfolios.
    What is DAWN Investor Sentiment?
    DAWN’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of DAWN in the last 7 days?
      >0.1% of TipRanks' retail investors changed their holding of DAWN in the last 7 days.
        What percentage of retail investors changed their holding of DAWN in the last 30 days?
        ▼ 6.3% of TipRanks' retail investors changed their holding of DAWN in the last 30 days.
          What is the average age of retail investors who hold DAWN?
          The average age of DAWN Holders is over 55.
            What other stocks have DAWN investors also bought?
            DAWN Investors also bought VKTX, DAL, CVS, RIOT, NIO, MARA, LCID, XYZ, ABT, RXRX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis